SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and...
Myriad
Myriad Genetics (NASDAQ: MYGN) has announced a collaboration with Flatiron Health to integrate its MyRisk®...
Myriad Genetics, Inc.Myriad’s MyRisk® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR®SALT LAKE CITY, Oct. 15, 2024 (GLOBE...